Stephan Jackman - 28 Apr 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALZN
Reported as of: 28 Apr 2023
Net transaction value: +$19,998
SEC form: 4
Accepted by SEC: 02 May 2023, 16:30:26 UTC
Prior SEC filing: 30 Nov 2022
Next SEC filing: 04 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephan Jackman

Key filing fact

Stephan Jackman filed Form 4 for Alzamend Neuro, Inc. (ALZN) on 02 May 2023.

Key facts

This page summarizes Stephan Jackman's Form 4 filing for Alzamend Neuro, Inc. (ALZN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 May 2023, 16:30.

Change

Previous filing in this sequence was filed on 30 Nov 2022.
Current net transaction value: +$19,998.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALZN transaction

Common Stock

Purchase

Transaction value: $19,998
Shares: +37,000
Change %: +435%
Price: $0.5405
Shares after: 45,500
Date: 28 Apr 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.